Header Logo

Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.

Kay J, Cross RK, Feldman SR, Park Y, Hanauer SB. Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases. Adv Ther. 2024 02; 41(2):509-533.

View in: PubMed